Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug

  • by
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.